| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| 10mg | |||
| Other Sizes |
| Targets |
EZH2 17 nM (IC50)
EZH2 (enhancer of zeste homolog 2), the catalytic subunit of the polycomb repressive complex 2 (PRC2). UNC2399 inhibits EZH2 methyltransferase activity, thereby reducing histone H3 lysine 27 trimethylation (H3K27me3). |
|---|---|
| ln Vitro |
In the EZH2 radioactive biochemical experiment, UNC2399 (1-1000 nM) exhibits high in vitro potency (IC50=17±2 nM)[1]. UNC2399 (100 μM) enhances EZH2 in lysates from HEK293T cells[1].
UNC2399 maintains high in vitro potency against EZH2 with an IC₅0 of 17 nM. As a biotinylated probe, it can be used in pull-down assays to study EZH2 interactions and identify EZH2-associated proteins in cells. UNC2399 (100 microM) has been used in biochemical assays. |
| ln Vivo |
No in vivo activity data has been reported for UNC2399 in available literature. As a biotinylated chemical probe, it is primarily used in biochemical and cell-based pull-down assays.
|
| Enzyme Assay |
EZH2 inhibition assays: UNC2399 is incubated with purified EZH2 enzyme (PRC2 complex) and its substrate (histone H3 or peptide) in the presence of S-adenosylmethionine (SAM). Methyltransferase activity is measured by detecting H3K27me3 levels. IC₅0 values are calculated from dose-response curves.
|
| Cell Assay |
UNC2399 is used in biotin pull-down assays: Cells are lysed and incubated with UNC2399-conjugated streptavidin beads. Bound proteins are eluted and identified by mass spectrometry or Western blot. This allows identification of EZH2-interacting proteins and validation of target engagement.
|
| Animal Protocol |
No in vivo animal model data has been reported for UNC2399. As a biotinylated probe, it is primarily used in biochemical and cell-based studies. It could potentially be used in vivo for target engagement studies.
|
| ADME/Pharmacokinetics |
UNC2399 has a molecular weight of 1353.66 and a molecular formula of C₆₇H104N10O1₇S. It is a biotinylated compound, which enables affinity purification and detection using streptavidin-based methods. Detailed PK parameters have not been reported.
|
| Toxicity/Toxicokinetics |
No toxicity data has been published for UNC2399. As a research compound and chemical probe, it is not intended for human therapeutic use. Biotinylated probes are generally considered safe for standard laboratory use.
|
| References | |
| Additional Infomation |
UNC2399 is a biotinylated version of UNC1999, a selective EZH2 inhibitor. It maintains high in vitro potency against EZH2 (IC₅0 = 17 nM) and is used as a chemical probe for pull-down assays to study EZH2 interactions. The compound is for research use only and has not entered clinical trials.
|
| Molecular Formula |
C67H104N10O17S
|
|---|---|
| Molecular Weight |
1353.66
|
| Exact Mass |
1352.73
|
| CAS # |
2412791-72-9
|
| PubChem CID |
118732748
|
| Appearance |
Light yellow to brown ointment
|
| LogP |
1.5
|
| Hydrogen Bond Donor Count |
5
|
| Hydrogen Bond Acceptor Count |
21
|
| Rotatable Bond Count |
52
|
| Heavy Atom Count |
95
|
| Complexity |
2270
|
| Defined Atom Stereocenter Count |
3
|
| SMILES |
CCCC1=C(C(=O)NC(=C1)C)CNC(=O)C2=C3C=NN(C3=CC(=C2)C4=CN=C(C=C4)N5CCN(CC5)C(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CCCC[C@H]6[C@@H]7[C@H](CS6)NC(=O)N7)C(C)C
|
| InChi Key |
PSDIDGKZEPMSHC-FRQYIUQJSA-N
|
| InChi Code |
InChI=1S/C67H104N10O17S/c1-5-8-52-43-51(4)72-66(81)56(52)47-70-65(80)55-44-54(45-59-57(55)48-71-77(59)50(2)3)53-11-12-61(69-46-53)75-15-17-76(18-16-75)63(79)13-19-83-21-23-85-25-27-87-29-31-89-33-35-91-37-39-93-41-42-94-40-38-92-36-34-90-32-30-88-28-26-86-24-22-84-20-14-68-62(78)10-7-6-9-60-64-58(49-95-60)73-67(82)74-64/h11-12,43-46,48,50,58,60,64H,5-10,13-42,47,49H2,1-4H3,(H,68,78)(H,70,80)(H,72,81)(H2,73,74,82)/t58-,60-,64-/m0/s1
|
| Chemical Name |
6-[6-[4-[3-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoyl]piperazin-1-yl]pyridin-3-yl]-N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-1-propan-2-ylindazole-4-carboxamide
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : 100 mg/mL (73.87 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (1.85 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (1.85 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (1.85 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 0.7387 mL | 3.6937 mL | 7.3874 mL | |
| 5 mM | 0.1477 mL | 0.7387 mL | 1.4775 mL | |
| 10 mM | 0.0739 mL | 0.3694 mL | 0.7387 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
